Literature DB >> 2449440

DNA amplification in tunicamycin-resistant Leishmania mexicana. Multicopies of a single 63-kilobase supercoiled molecule and their expression.

S Detke1, G Chaudhuri, J A Kink, K P Chang.   

Abstract

Tunicamycin-resistant variants of Leishmania mexicana were found to contain elevated activity of N-acetylglucosamine-1-phosphate transferase and amplified DNA (Kink, J. A., and Chang, K.-P. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 1253-1257). Complete digestion of their DNA with restriction endonucleases produced discrete ethidium bromide-staining bands after agarose gel electrophoresis. All four BamHI fragments of the amplified DNA were cloned separately into pBR322 and found to share no substantial sequence homology. DNA complementary to each of the cloned fragments is 64-128-fold more abundant in the variants than in the wild type cells. The amplified DNA appears to originate from a single chromosomal region of 63 kilobases. Individual copies of the 63 kilobases are each circularized at the newly formed junction site producing multiple extrachromosomal supercoiled molecules in the drug-resistant cells. There is overproduction of RNA ranging in size from 1.9 to 6.6 kilobases complementary to the amplified DNA in these cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2449440

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Extrachromosomal genetic complementation of surface metalloproteinase (gp63)-deficient Leishmania increases their binding to macrophages.

Authors:  X Liu; K P Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  Transcriptional mapping of the amplified region encoding the dihydrofolate reductase-thymidylate synthase of Leishmania major reveals a high density of transcripts, including overlapping and antisense RNAs.

Authors:  G M Kapler; S M Beverley
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

3.  Surface Zn-proteinase as a molecule for defense of Leishmania mexicana amazonensis promastigotes against cytolysis inside macrophage phagolysosomes.

Authors:  M B Seay; P L Heard; G Chaudhuri
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

4.  Amplified DNAs in laboratory stocks of Leishmania tarentolae: extrachromosomal circles structurally and functionally similar to the inverted-H-region amplification of methotrexate-resistant Leishmania major.

Authors:  M L Petrillo-Peixoto; S M Beverley
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

5.  Homologous recombination between direct repeat sequences yields P-glycoprotein containing amplicons in arsenite resistant Leishmania.

Authors:  K Grondin; B Papadopoulou; M Ouellette
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

6.  The 63-kilobase circular amplicon of tunicamycin-resistant Leishmania amazonensis contains a functional N-acetylglucosamine-1-phosphate transferase gene that can be used as a dominant selectable marker in transfection.

Authors:  X Liu; K P Chang
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

7.  Stable transfection of the human parasite Leishmania major delineates a 30-kilobase region sufficient for extrachromosomal replication and expression.

Authors:  G M Kapler; C M Coburn; S M Beverley
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

8.  Unstable amplification of two extrachromosomal elements in alpha-difluoromethylornithine-resistant Leishmania donovani.

Authors:  S Hanson; S M Beverley; W Wagner; B Ullman
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

9.  Direct and inverted DNA repeats associated with P-glycoprotein gene amplification in drug resistant Leishmania.

Authors:  M Ouellette; E Hettema; D Wüst; F Fase-Fowler; P Borst
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

10.  Physiological consequences of drug resistance in Leishmania and their relevance for chemotherapy.

Authors:  Alicia Ponte-Sucre
Journal:  Kinetoplastid Biol Dis       Date:  2003-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.